I am not sure if this is the reason. But Atomo did re-package the carestart tests in their own boxes.
In the end I question if this was necessary. In any case they were a week or two too slow and fell the wrong side of TGA demanding data, which required overseas testing.
It would not have saved the share price, which is in step with all the other diagnostics companies, LDX etc
Ann: Quarterly Activity Report - 30 June 2022, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
